University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult Patients

Phase 4

Not yet recruiting

Conditions: Surgery
Hip-fracture

Interventions: Drug: Intravenous (IV) placebo plus oral acetaminophen
Drug: Intravenous (IV) acetaminophen + oral placebo

First Posted Date: 2022-06-21

Last Posted Date: 2022-11-02

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 42

Registration Number: NCT05425355

Rehabilitation for People With Advanced Cancer

Not Applicable

Recruiting

Conditions: Advanced Colorectal Cancer
Cancer Rehabilitation
Advanced Breast Cancer

Interventions: Behavioral: Virtual rehabilitation group
Behavioral: In-person rehabilitaiton group

First Posted Date: 2022-06-21

Last Posted Date: 2024-10-10

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 117

Registration Number: NCT05424068

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC

Phase 2

Recruiting

Conditions: Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

Interventions: Biological: AZD2936

First Posted Date: 2022-06-10

Last Posted Date: 2023-10-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 200

Registration Number: NCT05414032

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Canada

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Recruiting

Conditions: Kidney Cancer
Pancreas Cancer
Leukemia
Solid Tumor
Colorectal Cancer
Breast Cancer
Head and Neck Cancer
Lung Cancer
Prostate Cancer
Melanoma

First Posted Date: 2022-06-03

Last Posted Date: 2024-06-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 500

Registration Number: NCT05403177

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)

Phase 2

Recruiting

Conditions: Metastatic Prostate Cancer

Interventions: Other: Standard of Care SBRT and ADT
Drug: Enzalutamide

First Posted Date: 2022-06-03

Last Posted Date: 2024-11-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 132

Registration Number: NCT05404139

Locations: 🇨🇦
Princess Margaret Cancer Center, Toronto, Ontario, Canada
🇨🇦
Sunnybrook Research Institute, Toronto, Ontartio, Canada

Biofeedback for Hemianopia Vision Rehabilitation

Not Applicable

Conditions: Brain Injury
Brain Tumor
Stroke
Hemianopsia, Homonymous
Brain Trauma

Interventions: Device: Biofeedback training

First Posted Date: 2022-05-31

Last Posted Date: 2022-05-31

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 32

Registration Number: NCT05397873

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease

Phase 2

Recruiting

Conditions: HER2-positive Breast Cancer
Breast Cancer

Interventions: Drug: Neratinib

First Posted Date: 2022-05-24

Last Posted Date: 2023-08-02

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 15

Registration Number: NCT05388149

Locations: 🇨🇦
University Health Network: Princess Margaret Cancer Centre, Toronto, Ontario, Canada

......SMARTEST Trial......

Phase 2

Recruiting

Conditions: Mesothelioma, Malignant

Interventions: Drug: Tremelimumab
Drug: Cyclophosphamide
Drug: Durvalumab

First Posted Date: 2022-05-19

Last Posted Date: 2023-12-14

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT05380713

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Development and Validation of an Online Independent Training Program for TOR-BSST© Dysphagia Screeners

Not Applicable

Completed

Conditions: Dysphagia
Stroke

Interventions: Other: Standard TOR-BSST© Training
Other: TOR-BSST© eLearning Training

First Posted Date: 2022-05-18

Last Posted Date: 2023-06-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 82

Registration Number: NCT05379699

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient

Not Applicable

Active, not recruiting

Conditions: Small Cell Carcinoma, Hypercalcaemic Type
Ovarian Cancer

Interventions: Drug: Pembrolizumab

First Posted Date: 2022-05-10

Last Posted Date: 2024-03-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 1

Registration Number: NCT05368207

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy